Filters
Chronic kidney disease (CKD) contributes to an increased risk of visual impairment and eye diseases in Asian adults, according to new research.
Nearly half of surgical procedures in children with glaucoma end in failure, and the most common reason for this is inadequate intraocular pressure (IOP) reduction, reveals a study.
Delayed rod-mediated dark adaptation (RMDA) is associated with the incidence and progression of age-related macular degeneration (AMD) over 3 years in healthy eyes or those with early AMD at baseline, reports a study.
New drug applications approved by US FDA as of 1-15 October 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Sleep disorders such as insomnia and sleep-associated apnoea appear to contribute to an increased risk of glaucoma, according to a study.
In patients with chronic ischaemic heart disease (IHD), the use of oral nitrates helps lower the risk of open-angle glaucoma (OAG) and primary open-angle glaucoma (POAG), according to a retrospective study.
Lowering the systolic blood pressure (SBP) target to <120 mm Hg compared with <140 mm Hg has a beneficial effect on retinal microvasculature among hypertensive patients with high cardiovascular risk, suggests a recent study.
A study from Singapore underscores the potential of a retinal ageing biomarker derived from retinal photography as a prognostic biomarker for cognitive decline and incident dementia.
Treatment with corticosteroid (CTC) plus conventional disease-modifying antirheumatic drug (C-DMARD) demonstrates an acceptable safety profile and appears to be more efficient than CTC alone in patients with nonanterior sarcoidosis-related uveitis, reports a study.
Infection with the human papillomavirus (HPV) appears to increase the risk of developing glaucoma, a recent study has shown.
